Patients with current or past antipsychotic usage are at risk of developing tardive dyskinesia. The MIND-TD questionnaire was developed to facilitate clinician-patient dialogues about the symptoms and impact of TD. Part 1 has "yes or no" questions about movement, impact, notice, and daily activities. Part 2 has a thorough interview and a differentiation checklist to elicit more information about abnormal movements, as different drug-induced movement disorders require distinct treatment strategies.
Rakesh Jain MD Texas Tech University Health Sciences Center
Crystal Kelly Neurocrine Biosciences
Leslie Lundt MD Neurocrine Bioscience
Desiree Matthews MS Neurocrine Biosciences
Autumn Roque DNP, APRN, PHMNP-BC Neurocrine Biosciences
Dawn Vanderhoef PhD, DNP, PHMNP-BC, FAANP Monarch